Ed Tucker

Ed Tucker, M.D., is chief medical officer at Mirum Pharmaceuticals. In this role, he oversees clinical development, safety operations, safety science, and quality assurance to advance our development pipeline. Prior to joining Mirum, Dr. Tucker served as chief operating officer at Acerta Pharma LLC where he supported the first U.S. approval and launch of Calquence in 2017. Prior to joining Acerta, Dr. Tucker held leadership positions in clinical development, medical safety and medical affairs at Bayer AG, Janssen Pharmaceutica and Genentech, Inc.